Document is current

Article History

Received: 17 October 2023

Accepted: 4 February 2024

First Online: 8 March 2024

Declarations

:

: Ethical approval was obtained from Griffith University (Ref No: 2021/834). Written informed consent was obtained for each participant in the parent RCT.

: Not applicable.

: JAS, ERY, RSW, MM, MM, JG, KRC, AR, HY have no conflicts to disclose. NM: Griffith University and The University of Queensland have received on her behalf investigator-initiated grants from 3 M, Cardinal Health and Eloquest, and consultancy payments from 3 M and Becton Dickinson for expert advice/ educational sessions. EL: EL’s affiliate (University of Queensland) has received, on her behalf: an investigator-initiated research grant from Eloquest Healthcare, unrelated to this work; EL was also awarded scholarship for conference attendance, by Angiodynamics, unrelated to this work. AC: ACs employer, on my behalf, has received investigator-initiated grants from 3 M, Cardinal Health and Eloquest Healthcare. These grants are unrelated to this work. EA: EA’s employer (Southwestern Sydney Local Health District) has received investigator-initiated research grants from Becton Dickinson-Bard and Eloquest Healthcare. EA has also received consultancy payments for educational lectures/expert advice from 3 M and ITL medical. CMR: CMR’s employer’s (Griffith University or The University of Queensland) received on her behalf unrestricted research or education grants from 3 M, BD-Bard, Cardinal Health, Eloquest and consultancy payments from 3 M, BD-Bard and ITL Healthcare.